Type Congenic; Mutant Strain; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Mating System Wild-type x Heterozygote (Female x Male) 12-DEC-12 Mating System Heterozygote x Wild-type (Female x Male) 12-DEC-12 Species laboratory mouse Generation +pN1+N1 (20-MAR-13)
Generation DefinitionsDonating Investigator Beth Levine, University of Texas Southwestern Medical Description
Monoallelic deletion of the autophagy related beclin 1 (Becn1) gene is associated with 40-75% of human breast, ovarian and prostate cancers. 30% of mice heterozygous for the Becn1 allele exhibit tumors by 13-18 months of age. Tumor types include: lung carcinomas, hepatocellular carcinomas and lymphomas. In addition, mice develop hepatitis B virus-induced neoplasia, increased cellular proliferation and reduced autophagy. Homozygous deletion of the targeted allele results in embryonic lethality. Of note, mice on a C57BL/6 background have a brown coat color which is believed to be a result of the effect of the Becn1 mutation on melanogenesis. These mice may be useful for studies involving autophagy and negative cell growth and tumor suppression.Development
A targeting vector was designed to replace exons 1 and 2 with a neomycin resistance (neo) cassette. The construct was electroporated into 129X1/SvJ-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts and the resulting chimeric mice were bred to C57BL/6. Offspring were backcrossed to C57BL/6 for 50 generations, however, mice retain a brown coat color, which is believed to be a result of the role of Becn1 in melanogenesis. Upon arrival, mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
View Mammalian Phenotype Terms
Mammalian Phenotype Terms provided by MGI
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Becn1tm1Blev/Becn1+
involves: 129X1/SvJ * C57BL/6J
- mortality/aging
- premature death
- mutants show some tumor-associated mortality at 6 to 8 months of age (MGI Ref ID J:86953)
- tumorigenesis
- increased tumor incidence
- 15% of mutants at 13-18 months of age exhibit palpable tumors compared to 1% of wild-type mice (MGI Ref ID J:86953)
- increased lung adenoma incidence
- mutants have an increased frequency of lung lesions in earlier stages of neoplasia, including hyperplastic alveolar epithelium resembling human atypical adenomatous hyperplasia and bronchioalveolar adenomas composed of monomorphous cells with minimal cytologic atypia (MGI Ref ID J:86953)
- increased lymphoma incidence
- develop lymphomas that occur more frequently, at an earlier age, are more likely to present as palpable masses than in wild-type, including diffuse large-cell lymphoma, follicular lymphoma, immunoblastic variant of diffuse large-cell lymphoma, anaplastic plasmacytoma, and histiocytic sarcoma (MGI Ref ID J:86953)
- increased mammary gland tumor incidence
- proliferative lesions (mammary intraepithelial neoplasia, adenomyoepithelioma, and acinar neoplasia) are present in mammary gland of 13 to 18 month old mutants (MGI Ref ID J:86953)
- increased plasmacytoma incidence
- anaplastic plasmacytoma (MGI Ref ID J:86953)
- malignant tumors
- mutants have a higher probability of having a malignancy (30%) than wild-type (14%); malignancies do not contain mutations in the wild-type Becn1 allele (MGI Ref ID J:86953)
- hepatocellular carcinoma
- well-differentiated hepatocellular carcinomas (MGI Ref ID J:86953)
- increased histiocytic sarcoma incidence (MGI Ref ID J:86953)
- lung carcinoma
- greater number of and larger lung carcinomas than in wild-type mice (MGI Ref ID J:86953)
- lung adenocarcinoma
- lung cancers show features of well-differentiated human papillary adenocarcinomas (MGI Ref ID J:86953)
- cellular phenotype
- abnormal autophagy
- germinal center B lymphocytes have fewer autophagic vacuoles than wild-type lymphocytes 10 days after immunization with sheep red blood cells, indicating reduced autophagic activity (MGI Ref ID J:86953)
- endocrine/exocrine gland phenotype
- abnormal mammary gland duct morphology
- mammary ducts are frequently abnormal, with multiple layers of epithelial cells and intraluminal collections of epithelial cells (MGI Ref ID J:86953)
- hyperproliferation of mammary ductal epithelial cells in the terminal end buds (MGI Ref ID J:86953)
- mammary ducts show increase in DNA synthesis (MGI Ref ID J:86953)
- hematopoietic system phenotype
- increased spleen germinal center number
- mutants show an increase in the number of germinal centeres in the spleens following immunization with sheep red blood cells at 2 months of age (MGI Ref ID J:86953)
- increased spleen germinal center size
- mutants show an increase in the size of germinal centers in the spleens following immunization with sheep red blood cells at 2 months of age (MGI Ref ID J:86953)
- immune system phenotype
- abnormal immune system morphology
- increase in frequency of extranodal, splenic, and nodal lymphoproliferative disease (MGI Ref ID J:86953)
- increased spleen germinal center number
- mutants show an increase in the number of germinal centeres in the spleens following immunization with sheep red blood cells at 2 months of age (MGI Ref ID J:86953)
- increased spleen germinal center size
- mutants show an increase in the size of germinal centers in the spleens following immunization with sheep red blood cells at 2 months of age (MGI Ref ID J:86953)
- integument phenotype
- abnormal mammary gland duct morphology
- mammary ducts are frequently abnormal, with multiple layers of epithelial cells and intraluminal collections of epithelial cells (MGI Ref ID J:86953)
- hyperproliferation of mammary ductal epithelial cells in the terminal end buds (MGI Ref ID J:86953)
- mammary ducts show increase in DNA synthesis (MGI Ref ID J:86953)
Becn1tm1Blev/Becn1tm1Blev
involves: 129X1/SvJ * C57BL/6J
- mortality/aging
- complete prenatal lethality
- embryonic lethality, time not specified (MGI Ref ID J:86953)
Becn1tm1Blev/Becn1tm1Blev
involves: 129X1/SvJ
- cardiovascular system phenotype
- decreased myocardial infarction size
- following ischemia and reperfusion with SB216763 (a GSK3b inhibitor) and rapamycin treatment (MGI Ref ID J:186597)
- increased myocardial infarction size
- homeostasis/metabolism phenotype
- decreased myocardial infarction size
- following ischemia and reperfusion with SB216763 (a GSK3b inhibitor) and rapamycin treatment (MGI Ref ID J:186597)
- increased myocardial infarction size
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cancer Research
Increased Tumor Incidence
Adenomas: lung
Hepatomas: hepatacellular carcinoma
Lymphomas
Developmental Biology Research
Embryonic Lethality (Homozygous)
| Allele Symbol | Becn1tm1Blev | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Beth Levine | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | beclin 1-; | ||
| Mutation Made By | Beth Levine, University of Texas Southwestern Medical | ||
| Strain of Origin | 129X1/SvJ | ||
| Gene Symbol and Name | Becn1, beclin 1, autophagy related | ||
| Chromosome | 11 | ||
| Gene Common Name(s) | ATG6; MGC:6843; VPS30; beclin1; | ||
| Molecular Note | Exons 1 and 2 were replace with a neomycin selection cassette inserted by homologous recombination. [MGI Ref ID J:86953] | ||
Genotyping Protocols
Becn1tm1Blev,Separated MCA
Becn1tm1Blev, Separated PCR
Helpful Links
Genotyping resources and troubleshooting
Qu X; Yu J; Bhagat G; Furuya N; Hibshoosh H; Troxel A; Rosen J; Eskelinen EL; Mizushima N; Ohsumi Y; Cattoretti G; Levine B. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112(12):1809-20. [PubMed: 14638851] [MGI Ref ID J:86953]
Becn1tm1Blev relatedFujimoto K; Hanson PT; Tran H; Ford EL; Han Z; Johnson JD; Schmidt RE; Green KG; Wice BM; Polonsky KS. 2009. Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation. J Biol Chem 284(40):27664-73. [PubMed: 19654319] [MGI Ref ID J:155712]
Germain M; Nguyen AP; Le Grand JN; Arbour N; Vanderluit JL; Park DS; Opferman JT; Slack RS. 2011. MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner. EMBO J 30(2):395-407. [PubMed: 21139567] [MGI Ref ID J:168794]
Hariharan N; Ikeda Y; Hong C; Alcendor RR; Usui S; Gao S; Maejima Y; Sadoshima J. 2013. Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One 8(1):e51632. [PubMed: 23308102] [MGI Ref ID J:195814]
He C; Bassik MC; Moresi V; Sun K; Wei Y; Zou Z; An Z; Loh J; Fisher J; Sun Q; Korsmeyer S; Packer M; May HI; Hill JA; Virgin HW; Gilpin C; Xiao G; Bassel-Duby R; Scherer PE; Levine B. 2012. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481(7382):511-5. [PubMed: 22258505] [MGI Ref ID J:181308]
Kim SI; Na HJ; Ding Y; Wang Z; Lee SJ; Choi ME. 2012. Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-beta1. J Biol Chem 287(15):11677-88. [PubMed: 22351764] [MGI Ref ID J:184288]
Matsui Y; Takagi H; Qu X; Abdellatif M; Sakoda H; Asano T; Levine B; Sadoshima J. 2007. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100(6):914-22. [PubMed: 17332429] [MGI Ref ID J:133796]
Nakahira K; Haspel JA; Rathinam VA; Lee SJ; Dolinay T; Lam HC; Englert JA; Rabinovitch M; Cernadas M; Kim HP; Fitzgerald KA; Ryter SW; Choi AM. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12(3):222-30. [PubMed: 21151103] [MGI Ref ID J:169252]
Niu H; Xiong Q; Yamamoto A; Hayashi-Nishino M; Rikihisa Y. 2012. Autophagosomes induced by a bacterial Beclin 1 binding protein facilitate obligatory intracellular infection. Proc Natl Acad Sci U S A 109(51):20800-7. [PubMed: 23197835] [MGI Ref ID J:193111]
Parkhitko A; Myachina F; Morrison TA; Hindi KM; Auricchio N; Karbowniczek M; Wu JJ; Finkel T; Kwiatkowski DJ; Yu JJ; Henske EP. 2011. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci U S A 108(30):12455-60. [PubMed: 21746920] [MGI Ref ID J:174534]
Pickford F; Masliah E; Britschgi M; Lucin K; Narasimhan R; Jaeger PA; Small S; Spencer B; Rockenstein E; Levine B; Wyss-Coray T. 2008. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118(6):2190-9. [PubMed: 18497889] [MGI Ref ID J:137727]
Portillo JA; Okenka G; Reed E; Subauste A; Van Grol J; Gentil K; Komatsu M; Tanaka K; Landreth G; Levine B; Subauste CS. 2010. The CD40-autophagy pathway is needed for host protection despite IFN-Gamma-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 5(12):e14472. [PubMed: 21217818] [MGI Ref ID J:168250]
Tannous P; Zhu H; Johnstone JL; Shelton JM; Rajasekaran NS; Benjamin IJ; Nguyen L; Gerard RD; Levine B; Rothermel BA; Hill JA. 2008. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 105(28):9745-50. [PubMed: 18621691] [MGI Ref ID J:137839]
Zhai P; Sciarretta S; Galeotti J; Volpe M; Sadoshima J. 2011. Differential roles of GSK-3beta during myocardial ischemia and ischemia/reperfusion. Circ Res 109(5):502-11. [PubMed: 21737790] [MGI Ref ID J:186597]
Zhu H; Tannous P; Johnstone JL; Kong Y; Shelton JM; Richardson JA; Le V; Levine B; Rothermel BA; Hill JA. 2007. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 117(7):1782-93. [PubMed: 17607355] [MGI Ref ID J:124190]
Animal Health Reports
Room Number MGL375
Colony Maintenance
Breeding & Husbandry While maintaining a live colony, these mice are bred as heterozygotes. Mice homozygous for the mutation are not viable. Of note, mice on a C57BL/6 background have a brown coat color which is believed to be a result of the Becn1 mutation on melanogenesis. Mating System Wild-type x Heterozygote (Female x Male) 12-DEC-12 Heterozygote x Wild-type (Female x Male) 12-DEC-12
| Pricing for USA, Canada and Mexico shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $232.00 Female or Male Heterozygous for Becn1tm1Blev
Price per Pair (US dollars $) Pair Genotype $296.00 Heterozygous for Becn1tm1Blev x Wild-type for Becn1tm1Blev $296.00 Wild-type for Becn1tm1Blev x Heterozygous for Becn1tm1Blev Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Pricing for International shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $301.60 Female or Male Heterozygous for Becn1tm1Blev
Price per Pair (US dollars $) Pair Genotype $384.80 Heterozygous for Becn1tm1Blev x Wild-type for Becn1tm1Blev $384.80 Wild-type for Becn1tm1Blev x Heterozygous for Becn1tm1Blev Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
|
|
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.